Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,270 publicly listed stocks with a combined market cap of $1.89 Trillion. Alzinova AB leads the sector with a market cap of $7.97 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.89 Trillion
Companies Listed
1,270
Largest Company
Alzinova AB
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1051 |
Alzinova AB
ST:ALZ |
$7.97 Million | Skr74.07 Million | Sweden | Skr0.48 | +0.74% | +3.91% | 27.20 Million |
| 1052 |
Imunon Inc
NASDAQ:IMNN |
$7.90 Million | $7.90 Million | USA | $1.88 | -3.59% | -6.47% | 1.28 Million |
| 1053 |
Addex Therapeutics Ltd
NASDAQ:ADXN |
$7.86 Million | $7.86 Million | USA | $6.21 | +3.50% | +5.97% | 74.70K |
| 1054 |
Bergenbio ASA
OL:BGBIO |
$7.75 Million | Nkr73.62 Million | Norway | Nkr0.47 | -5.91% | -61.29% | 13.59 Million |
| 1055 |
Modus Therapeutics Holding AB
ST:MODTX |
$7.62 Million | Skr70.84 Million | Sweden | Skr0.40 | -5.62% | -16.56% | 24.51 Million |
| 1056 |
PharmaCyte Biotech Inc
NASDAQ:PMCB |
$7.51 Million | $7.51 Million | USA | $0.83 | +2.16% | +18.29% | 6.39 Million |
| 1057 |
Hemostemix Inc
V:HEM |
$7.50 Million | CA$10.37 Million | Canada | CA$0.06 | +0.00% | +10.00% | 932.31K |
| 1058 |
Synlogic Inc
NASDAQ:SYBX |
$7.49 Million | $7.49 Million | USA | $0.74 | -1.33% | +7.25% | 291.84K |
| 1059 |
NuCana PLC
NASDAQ:NCNA |
$7.45 Million | $7.45 Million | USA | $1.79 | -6.77% | -12.68% | 1.18 Million |
| 1060 |
Entero Therapeutics, Inc.
NASDAQ:GRDX |
$7.40 Million | $7.40 Million | USA | $5.09 | +4.73% | -18.17% | 3.65 Million |
| 1061 |
TME Pharma N.V.
PA:ALTME |
$7.34 Million | €6.28 Million | France | €0.08 | -0.88% | -3.66% | 4.11 Million |
| 1062 |
ONCODES.PREC.MED. EO-34
F:ZR8 |
$7.29 Million | €6.24 Million | Germany | €0.33 | +0.93% | +0.93% | 0.00 |
| 1063 |
Aspire BioPharma, Inc.
NASDAQ:ASBP |
$7.27 Million | $7.27 Million | USA | $6.19 | +9.56% | -6.92% | 22.02 Million |
| 1064 |
Akari Therapeutics PLC
NASDAQ:AKTX |
$7.15 Million | $7.15 Million | USA | $13.00 | -1.29% | -15.83% | 40.38 Million |
| 1065 |
Plant Advanced Technologies SA
PA:ALPAT |
$7.15 Million | €6.12 Million | France | €6.75 | +0.00% | +0.75% | 3.75K |
| 1066 |
Addex Therapeutics Ltd
SW:ADXN |
$6.98 Million | CHF5.52 Million | Switzerland | CHF0.04 | -4.80% | +0.93% | 3.90 Million |
| 1067 |
INVEX Therapeutics Ltd
AU:IXC |
$6.91 Million | AU$9.77 Million | Australia | AU$0.13 | +0.00% | +18.18% | 815.40K |
| 1068 |
TME PHARM.CONF.IPO EO 1-
F:0N6A |
$6.88 Million | €5.89 Million | Germany | €0.07 | +0.00% | -4.02% | 0.00 |
| 1069 |
NextCure Inc
NASDAQ:NXTC |
$6.87 Million | $6.87 Million | USA | $1.96 | -1.01% | -29.75% | 3.08 Million |
| 1070 |
Pila Pharma AB
ST:PILA |
$6.86 Million | Skr63.73 Million | Sweden | Skr1.40 | +0.00% | -2.79% | 1.50 Million |
| 1071 |
TNF Pharmaceuticals, Inc.
NASDAQ:TNFA |
$6.80 Million | $6.80 Million | USA | $3.68 | -7.31% | -12.38% | 74.17 Million |
| 1072 |
CNS Pharmaceuticals Inc
NASDAQ:CNSP |
$6.77 Million | $6.77 Million | USA | $4.63 | -2.32% | -5.32% | 1.71 Million |
| 1073 |
Traws Pharma Inc
NASDAQ:TRAW |
$6.68 Million | $6.68 Million | USA | $0.84 | +10.58% | -38.99% | 19.51 Million |
| 1074 |
BRITANNIA LIFE SCIENCES
F:L020 |
$6.54 Million | €5.60 Million | Germany | €0.03 | -9.21% | -9.21% | 0.00 |
| 1075 |
Immuron Ltd ADR
NASDAQ:IMRN |
$6.45 Million | $6.45 Million | USA | $0.88 | +0.40% | +6.82% | 689.90K |
| 1076 |
Pure Biologics Spólka Akcyjna
WAR:PUR |
$6.44 Million | zł23.40 Million | Poland | zł2.07 | -5.28% | -14.67% | 7.21 Million |
| 1077 |
Silo Pharma Inc
NASDAQ:SILO |
$6.40 Million | $6.40 Million | USA | $6.25 | -1.26% | -0.16% | 2.31 Million |
| 1078 |
Can Fite Biopharma Ltd ADR
NYSE MKT:CANF |
$6.23 Million | $6.23 Million | USA | $2.91 | -1.69% | -8.20% | 734.49K |
| 1079 |
Titan Pharmaceuticals Inc
NASDAQ:TTNP |
$6.13 Million | $6.13 Million | USA | $4.61 | +0.00% | +7.63% | 2.76 Million |
| 1080 |
Moolec Science SA Ordinary Shares
NASDAQ:MLEC |
$5.71 Million | $5.71 Million | USA | $7.86 | +3.01% | +10.08% | 693.14K |
| 1081 |
Aptevo Therapeutics Inc
NASDAQ:APVO |
$5.66 Million | $5.66 Million | USA | $4.54 | -3.40% | -7.16% | 743.93K |
| 1082 |
Clearmind Medicine Inc. Common Shares
NASDAQ:CMND |
$5.61 Million | $5.61 Million | USA | $3.14 | -6.82% | -17.15% | 167.82 Million |
| 1083 |
Processa Pharmaceuticals Inc
NASDAQ:PCSA |
$5.56 Million | $5.56 Million | USA | $2.09 | -5.43% | -13.64% | 1.88 Million |
| 1084 |
Bioatla Inc
NASDAQ:BCAB |
$5.53 Million | $5.53 Million | USA | $3.45 | -4.70% | +4.23% | 1.25 Million |
| 1085 |
Vectus Biosystems Ltd
AU:VBS |
$5.48 Million | AU$7.75 Million | Australia | AU$0.15 | +0.00% | +16.00% | 1.77 Million |
| 1086 |
Adial Pharmaceuticals Inc
NASDAQ:ADIL |
$5.44 Million | $5.44 Million | USA | $2.54 | -10.88% | +14.93% | 25.18 Million |
| 1087 |
Pulmatrix Inc
NASDAQ:PULM |
$5.44 Million | $5.44 Million | USA | $1.49 | +5.67% | +4.93% | 632.37K |
| 1088 |
BetterLife Pharma Inc
F:NPAU |
$5.42 Million | €4.64 Million | Germany | €0.04 | +4.29% | +15.87% | 1.14K |
| 1089 |
Cardio Diagnostics Holdings Inc
NASDAQ:CDIO |
$5.42 Million | $5.42 Million | USA | $1.96 | -0.51% | -1.51% | 1.61 Million |
| 1090 |
Adalta Ltd
AU:1AD |
$5.41 Million | AU$7.65 Million | Australia | AU$0.00 | -25.00% | -25.00% | 57.28 Million |
| 1091 |
Alaunos Therapeutics Inc
NASDAQ:TCRT |
$5.38 Million | $5.38 Million | USA | $2.24 | -1.75% | +12.00% | 450.92K |
| 1092 |
Aptorum Group Ltd Class A
NASDAQ:APM |
$5.35 Million | $5.35 Million | USA | $0.84 | -3.08% | -27.98% | 7.15 Million |
| 1093 |
Exact Therapeutics AS
OL:EXTX |
$5.33 Million | Nkr50.61 Million | Norway | Nkr0.80 | +2.56% | -4.76% | 3.41 Million |
| 1094 |
Combigene AB
ST:COMBI |
$5.24 Million | Skr48.71 Million | Sweden | Skr2.46 | +1.23% | +6.49% | 1.17 Million |
| 1095 |
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ:LIMN |
$5.11 Million | $5.11 Million | USA | $0.11 | -5.25% | -19.29% | 412.24 Million |
| 1096 |
Transcode Therapeutics Inc
NASDAQ:RNAZ |
$5.08 Million | $5.08 Million | USA | $5.54 | +1.28% | +8.84% | 2.94 Million |
| 1097 |
Can Fite Biopharma Ltd
TA:CANF |
$5.03 Million | ILA1.88 Billion | Israel | ILA438.00 | +2.82% | -4.53% | 342.87K |
| 1098 |
Quantum Genomics SA
PA:ALQGC |
$5.03 Million | €4.30 Million | France | €0.07 | +0.00% | +0.00% | 0.00 |
| 1099 |
Xenetic Biosciences Inc
NASDAQ:XBIO |
$4.98 Million | $4.98 Million | USA | $3.06 | -5.56% | -0.97% | 393.75K |
| 1100 |
ACRUX Ltd
AU:ACR |
$4.94 Million | AU$6.98 Million | Australia | AU$0.02 | +6.25% | +41.67% | 69.41 Million |
| 1101 |
Purple Biotech Ltd
TA:PPBT |
$4.84 Million | ILA1.81 Billion | Israel | ILA1.00 | +0.00% | +0.00% | 2.62 Million |
| 1102 |
Salarius Pharmaceuticals Inc
NASDAQ:SLRX |
$4.81 Million | $4.81 Million | USA | $0.82 | -2.40% | +26.59% | 14.81 Million |
| 1103 |
Dermata Therapeutics Inc
NASDAQ:DRMA |
$4.79 Million | $4.79 Million | USA | $1.19 | -0.83% | -1.65% | 1.25 Million |
| 1104 |
Bio-Gene Technology Ltd
AU:BGT |
$4.75 Million | AU$6.71 Million | Australia | AU$0.02 | +4.76% | +0.00% | 12.55 Million |
| 1105 |
Qualigen Therapeutics Inc
NASDAQ:QLGN |
$4.74 Million | $4.74 Million | USA | $2.33 | +0.30% | -8.98% | 2.43 Million |
| 1106 |
Mustang Bio Inc
NASDAQ:MBIO |
$4.74 Million | $4.74 Million | USA | $0.70 | -4.70% | +0.47% | 6.16 Million |
| 1107 |
Scisparc Ltd
NASDAQ:SPRC |
$4.61 Million | $4.61 Million | USA | $8.05 | -3.48% | -22.74% | 46.41 Million |
| 1108 |
Genprex Inc
NASDAQ:GNPX |
$4.61 Million | $4.61 Million | USA | $0.44 | -10.46% | -35.07% | 7.03 Million |
| 1109 |
Fluicell AB
ST:FLUI |
$4.58 Million | Skr42.58 Million | Sweden | Skr31.00 | -5.78% | -24.76% | 840.79K |
| 1110 |
Bio Green Med Solution, Inc.
NASDAQ:BGMS |
$4.53 Million | $4.53 Million | USA | $0.82 | -1.77% | -25.45% | 116.74 Million |
| 1111 |
2cureX AB
ST:2CUREX |
$4.43 Million | Skr41.17 Million | Sweden | Skr1.64 | -4.98% | -6.82% | 810.69K |
| 1112 |
Acurx Pharmaceuticals LLC
NASDAQ:ACXP |
$4.40 Million | $4.40 Million | USA | $1.54 | -1.91% | -4.94% | 2.23 Million |
| 1113 |
COLLPLANT BIOTECH. IS-01
F:CPT |
$4.34 Million | €3.71 Million | Germany | €0.27 | +0.00% | +0.00% | 0.00 |
| 1114 |
Soligenix Inc.
NASDAQ:SNGX |
$4.29 Million | $4.29 Million | USA | $0.43 | -5.45% | +0.69% | 363.13 Million |
| 1115 |
Collplant Biotechnologies Ltd
NASDAQ:CLGN |
$4.29 Million | $4.29 Million | USA | $0.34 | +0.60% | -9.46% | 1.81 Million |
| 1116 |
Quest PharmaTech Inc
V:QPT |
$4.28 Million | CA$5.92 Million | Canada | CA$0.04 | +0.00% | +16.67% | 862.76K |
| 1117 |
Tissue Repair Ltd
AU:TRP |
$4.28 Million | AU$6.05 Million | Australia | AU$0.10 | +0.00% | -4.76% | 654.86K |
| 1118 |
CASI Pharmaceuticals Inc
NASDAQ:CASI |
$4.26 Million | $4.26 Million | USA | $0.24 | +17.06% | -68.82% | 11.66 Million |
| 1119 |
Zelira Therapeutics Ltd
AU:ZLD |
$4.21 Million | AU$5.95 Million | Australia | AU$0.50 | +0.00% | +0.00% | 0.00 |
| 1120 |
Biophytis S.A.
NASDAQ:BPTSY |
$4.19 Million | $4.19 Million | USA | $2.08 | +0.00% | +0.00% | 0.00 |
| 1121 |
Inhalerx Ltd
AU:IRX |
$4.18 Million | AU$5.91 Million | Australia | AU$0.02 | +4.35% | +33.33% | 1.37 Million |
| 1122 |
GLOW LIFETECH CORP.
F:9DO |
$4.13 Million | €3.53 Million | Germany | €0.02 | -2.50% | +160.00% | 0.00 |
| 1123 |
Kineta, Inc.
NASDAQ:KANT |
$4.12 Million | $4.12 Million | USA | $0.34 | +0.00% | +31.80% | 100.29K |
| 1124 |
Matinas BioPharma Holdings Inc
NYSE MKT:MTNB |
$4.09 Million | $4.09 Million | USA | $0.70 | +5.09% | +23.06% | 7.31 Million |
| 1125 |
Aptose Biosciences Inc
TO:APS |
$4.06 Million | CA$5.62 Million | Canada | CA$2.20 | +3.29% | +0.00% | 65.95K |
| 1126 |
XTL Biopharmaceuticals Ltd
TA:XTLB |
$4.02 Million | ILA1.50 Billion | Israel | ILA1.70 | +0.00% | +0.00% | 88.34 Million |
| 1127 |
DMD Digital Health Connections Group Inc
NASDAQ:APTOF |
$4.01 Million | $4.01 Million | USA | $1.57 | -2.48% | +0.00% | 31.55K |
| 1128 |
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD |
$3.99 Million | $3.99 Million | USA | $0.60 | -1.90% | +28.77% | 26.09 Million |
| 1129 |
NLS Pharmaceutics AG
NASDAQ:NLSP |
$3.97 Million | $3.97 Million | USA | $0.76 | +2.97% | -52.08% | 43.52 Million |
| 1130 |
Kane Biotech Inc
V:KNE |
$3.95 Million | CA$5.46 Million | Canada | CA$0.03 | +0.00% | +0.00% | 5.74 Million |
| 1131 |
Indaptus Therapeutics Inc
NASDAQ:INDP |
$3.95 Million | $3.95 Million | USA | $3.72 | +0.81% | +77.14% | 55.68 Million |
| 1132 |
Innovotech Inc
V:IOT |
$3.94 Million | CA$5.44 Million | Canada | CA$0.10 | -4.76% | -9.09% | 1.86 Million |
| 1133 |
Evogene
TA:EVGN |
$3.94 Million | ILA1.47 Billion | Israel | ILA168.40 | +1.45% | -2.55% | 1.63 Million |
| 1134 |
Ensysce Biosciences Inc
NASDAQ:ENSC |
$3.90 Million | $3.90 Million | USA | $0.28 | +3.00% | +9.88% | 27.25 Million |
| 1135 |
Avacta Group PLC
LSE:AVCT |
$3.89 Million | GBX31.95 Billion | UK | GBX73.00 | +2.82% | +3.55% | 43.59 Million |
| 1136 |
60 Degrees Pharmaceuticals, Inc. Common Stock
NASDAQ:SXTP |
$3.85 Million | $3.85 Million | USA | $1.46 | -2.01% | +2.10% | 2.66 Million |
| 1137 |
GRI Bio Inc.
NASDAQ:GRI |
$3.84 Million | $3.84 Million | USA | $2.17 | -5.24% | +0.00% | 1.09 Million |
| 1138 |
Biotron Ltd
AU:BIT |
$3.82 Million | AU$5.40 Million | Australia | AU$0.00 | +0.00% | +0.00% | 16.22 Million |
| 1139 |
International Biotechnology Trust plc
LSE:IBT |
$3.75 Million | GBX30.82 Billion | UK | GBX966.00 | -0.82% | +3.43% | 1.06 Million |
| 1140 |
BIOVAXYS TECHNOLOGY CORP.
F:5LB |
$3.75 Million | €3.20 Million | Germany | €0.15 | +928.28% | +1320.00% | 30.67K |
| 1141 |
2CUREX AB SEK-10
F:2QE |
$3.63 Million | €3.10 Million | Germany | €0.15 | +3.66% | -2.80% | 0.00 |
| 1142 |
Revelation Biosciences Inc
NASDAQ:REVB |
$3.58 Million | $3.58 Million | USA | $0.96 | -3.04% | -4.85% | 989.84K |
| 1143 |
XORTX Therapeutics Inc
V:XRTX |
$3.55 Million | CA$4.91 Million | Canada | CA$3.00 | +0.00% | -5.06% | 32.64K |
| 1144 |
Conduit Pharmaceuticals Inc.
NASDAQ:CDT |
$3.49 Million | $3.49 Million | USA | $0.72 | +1.10% | -7.38% | 54.29 Million |
| 1145 |
Green Cross Holdings Preference Shares
KO:005257 |
$3.44 Million | ₩5.08 Billion | Korea | ₩21100.00 | +1.69% | +3.69% | 138.16K |
| 1146 |
Alzamend Neuro Inc
NASDAQ:ALZN |
$3.43 Million | $3.43 Million | USA | $1.28 | +4.07% | +10.34% | 1.55 Million |
| 1147 |
VivoSim Labs, Inc.
NASDAQ:VIVS |
$3.39 Million | $3.39 Million | USA | $1.17 | -3.31% | -1.68% | 1.22 Million |
| 1148 |
Guard Therapeutics International AB
ST:GUARD |
$3.36 Million | Skr31.26 Million | Sweden | Skr1.55 | -2.52% | +18.32% | 1.21 Million |
| 1149 |
PreveCeutical Medical Inc
F:18H |
$3.34 Million | €2.85 Million | Germany | €0.01 | -54.55% | -77.27% | 356.50K |
| 1150 |
BIOMIND LABS INC.
F:3XI |
$3.31 Million | €2.83 Million | Germany | €0.04 | +0.00% | -30.48% | 10.50K |
| 1151 |
Azitra Inc
NYSE MKT:AZTR |
$3.30 Million | $3.30 Million | USA | $0.20 | -3.77% | +10.57% | 13.26 Million |
| 1152 |
Opthea Limited
NASDAQ:OPTEY |
$3.25 Million | $3.25 Million | USA | $0.02 | -0.52% | +25.00% | 1.01 Million |
| 1153 |
Iterum Therapeutics PLC
NASDAQ:ITRM |
$3.20 Million | $3.20 Million | USA | $0.06 | -12.01% | +9.27% | 3.77 Million |
| 1154 |
Psyence Biomedical Ltd. Common Shares
NASDAQ:PBM |
$3.16 Million | $3.16 Million | USA | $3.17 | -3.94% | -11.94% | 2.42 Million |
| 1155 |
Propanc Biopharma, Inc. Common Stock
NASDAQ:PPCB |
$3.12 Million | $3.12 Million | USA | $1.93 | -10.23% | +40.88% | 182.24 Million |
| 1156 |
ValiRx plc
LSE:VAL |
$3.05 Million | £2.27 Million | UK | £0.19 | +0.00% | +2.78% | 525.20 Million |
| 1157 |
Decoy Therapeutics Inc.
NASDAQ:DCOY |
$2.93 Million | $2.93 Million | USA | $5.88 | -3.61% | -5.92% | 375.82K |
| 1158 |
LOBE SCIENCES LTD
F:6YX0 |
$2.90 Million | €2.48 Million | Germany | €0.03 | +21.95% | -5.66% | 48.00K |
| 1159 |
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB |
$2.79 Million | $2.79 Million | USA | $1.44 | -1.37% | -9.43% | 49.45 Million |
| 1160 |
Unity Biotechnology Inc
NASDAQ:UBX |
$2.75 Million | $2.75 Million | USA | $0.16 | -20.04% | -58.34% | 29.43 Million |
| 1161 |
Chimeric Therapeutics Ltd
AU:CHM |
$2.71 Million | AU$3.83 Million | Australia | AU$0.07 | +4.23% | -9.76% | 4.91 Million |
| 1162 |
Omega Therapeutics Inc
NASDAQ:OMGA |
$2.69 Million | $2.69 Million | USA | $0.05 | +0.00% | +0.00% | 105.64K |
| 1163 |
Calidi Biotherapeutics Inc.
NYSE MKT:CLDI |
$2.68 Million | $2.68 Million | USA | $0.18 | -8.29% | -7.32% | 212.03 Million |
| 1164 |
Artelo Biosciences Inc
NASDAQ:ARTL |
$2.60 Million | $2.60 Million | USA | $1.29 | -0.77% | -3.01% | 58.13 Million |
| 1165 |
GeoVax Labs Inc
NASDAQ:GOVX |
$2.60 Million | $2.60 Million | USA | $1.17 | -0.85% | -12.69% | 300.85 Million |
| 1166 |
Scancell Hldgs Plc
LSE:SCLP |
$2.59 Million | GBX21.27 Billion | UK | GBX20.50 | +1.23% | -5.75% | 70.74 Million |
| 1167 |
Palatin Technologies Inc
NYSE MKT:PTN |
$2.45 Million | $2.45 Million | USA | $23.00 | +4.59% | +0.00% | 243.66K |
| 1168 |
Magle Chemoswed Holding Ab
ST:MAGLE |
$2.44 Million | Skr22.71 Million | Sweden | Skr1.10 | -28.10% | -50.00% | 1.08 Million |
| 1169 |
Oragenics Inc
NYSE MKT:OGEN |
$2.42 Million | $2.42 Million | USA | $0.60 | +1.69% | +5.13% | 1.11 Million |
| 1170 |
Bone Biologics Corp
NASDAQ:BBLG |
$2.30 Million | $2.30 Million | USA | $1.38 | -4.17% | +10.40% | 535.82K |
| 1171 |
HCW Biologics Inc
NASDAQ:HCWB |
$2.29 Million | $2.29 Million | USA | $1.14 | -6.56% | -21.38% | 696.96 Million |
| 1172 |
Clearside Biomedical Inc
NASDAQ:CLSD |
$2.15 Million | $2.15 Million | USA | $0.41 | -26.96% | -85.66% | 12.52 Million |
| 1173 |
Rakovina Therapeutics Inc
V:RKV |
$2.14 Million | CA$2.96 Million | Canada | CA$0.14 | +0.00% | +0.00% | 735.70K |
| 1174 |
Abpro Holdings, Inc.
NYSE:ABP |
$2.00 Million | $2.00 Million | USA | $5.60 | +4.67% | +6.67% | 641.50K |
| 1175 |
Kancera AB (publ)
ST:KAN |
$1.98 Million | Skr18.44 Million | Sweden | Skr0.15 | -23.82% | -37.24% | 30.49 Million |
| 1176 |
PALATIN TECHS DL-01
F:PTN |
$1.97 Million | €1.68 Million | Germany | €3.30 | +0.00% | +0.00% | 0.00 |
| 1177 |
Medigene AG
XETRA:MDG1 |
$1.97 Million | €1.68 Million | Germany | €0.13 | +0.00% | +0.00% | 189.47K |
| 1178 |
Plantarc Bio Ltd
TA:PLNT |
$1.96 Million | ILA731.02 Million | Israel | ILA220.90 | +0.00% | +1.33% | 217.47K |
| 1179 |
Biodexa Pharmaceticals
NASDAQ:BDRX |
$1.93 Million | $1.93 Million | USA | $2.98 | -2.93% | -8.59% | 528.96K |
| 1180 |
Anatara Lifesciences Ltd
AU:ANR |
$1.92 Million | AU$2.72 Million | Australia | AU$0.01 | +22.22% | +22.22% | 20.24 Million |
| 1181 |
Biosergen AS
ST:BIOSGN |
$1.92 Million | Skr17.85 Million | Sweden | Skr7.60 | +0.00% | -6.17% | 38.95K |
| 1182 |
LakeShore Biopharma Co., Ltd
NYSE:LSBCF |
$1.85 Million | $1.85 Million | USA | $0.07 | -4.29% | -4.29% | 179.19K |
| 1183 |
Medesis Pharma SA
PA:ALMDP |
$1.80 Million | €1.54 Million | France | €0.35 | +0.00% | +0.00% | 0.00 |
| 1184 |
Valion Bio Inc
NASDAQ:VBIO |
$1.76 Million | $1.76 Million | USA | $0.56 | +0.09% | -26.86% | 9.46 Million |
| 1185 |
ExpreS2ion Biotech Holding AB
ST:EXPRS2 |
$1.69 Million | Skr15.71 Million | Sweden | Skr1.59 | -0.63% | -1.85% | 3.49 Million |
| 1186 |
Jaguar Animal Health Inc
NASDAQ:JAGX |
$1.67 Million | $1.67 Million | USA | $2.31 | -6.48% | -15.38% | 2.17 Million |
| 1187 |
ZyVersa Therapeutics Inc.
NASDAQ:ZVSA |
$1.58 Million | $1.58 Million | USA | $0.19 | -0.05% | +11.44% | 199.63K |
| 1188 |
BioSenic S.A.
BR:BIOS |
$1.57 Million | €1.34 Million | Belgium | €0.00 | +0.00% | +0.00% | 3.25 Million |
| 1189 |
Oncternal Therapeutics Inc
NASDAQ:ONCT |
$1.56 Million | $1.56 Million | USA | $0.53 | +0.00% | +0.00% | 0.00 |
| 1190 |
GEMINA LABS LTD
F:8I7 |
$1.53 Million | €1.31 Million | Germany | €0.02 | +0.00% | -16.28% | 4.50K |
| 1191 |
Purple Biotech
NASDAQ:PPBT |
$1.52 Million | $1.52 Million | USA | $1.64 | -2.96% | -43.84% | 17.93 Million |
| 1192 |
Hepion Pharmaceuticals Inc
NASDAQ:HEPA |
$1.50 Million | $1.50 Million | USA | $0.05 | -11.21% | -35.63% | 460.71K |
| 1193 |
Stayble Therapeutics AB
ST:STABL |
$1.42 Million | Skr13.19 Million | Sweden | Skr0.21 | +0.00% | +0.00% | 148.88 Million |
| 1194 |
Appili Therapeutics Inc
TO:APLI |
$1.39 Million | CA$1.93 Million | Canada | CA$0.02 | +0.00% | +0.00% | 1.25 Million |
| 1195 |
Scinai Immunotherapeutics Ltd
NASDAQ:SCNI |
$1.37 Million | $1.37 Million | USA | $0.35 | -4.77% | -14.87% | 10.80 Million |
| 1196 |
Biomx Inc
NYSE MKT:PHGE |
$1.25 Million | $1.25 Million | USA | $0.82 | +10.57% | +39.85% | 249.67 Million |
| 1197 |
XTL Biopharmaceuticals Ltd
F:H2K2 |
$1.19 Million | €1.02 Million | Germany | €2.28 | +23.24% | +408.93% | 47.11K |
| 1198 |
Virax Biolabs Group Limited Ordinary Shares
NASDAQ:VRAX |
$1.17 Million | $1.17 Million | USA | $0.16 | -9.20% | -24.81% | 1.05 Billion |
| 1199 |
Lyra Therapeutics Inc
NASDAQ:LYRA |
$1.15 Million | $1.15 Million | USA | $0.65 | +0.00% | -26.14% | 182.53K |
| 1200 |
Onconetix Inc
NASDAQ:ONCO |
$1.15 Million | $1.15 Million | USA | $1.08 | -0.92% | +6.93% | 182.26 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries